Vaccines

Vaccines Vaccination COVID-19 Infectious Diseases Public Health Health Policy Department of Health and Human Services Covid-19 Disease Outbreaks Vaccine Development

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.

Trump Administration Cuts Moderna Funding and Disbands mRNA Vaccine Panel

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine

Meghan McCain Criticized for Endorsing COVID-19 Vaccine Detox Product

U.S. Cancels Moderna’s $600 Million Bird Flu Vaccine Contract

HHS Withdraws $766 Million From Moderna’s Bird Flu Vaccine Program

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

FDA and CDC Pause Chikungunya Vaccine for Older Adults Over Safety Concerns

Measles Outbreak Surpasses 1,000 Cases Amid RFK Jr.'s Vaccine Misinformation

LC16m8 Vaccine Shows Strong Promise for Mpox Prevention in Latest Trials

HHS Secretary Kennedy's Vaccine Policies Deepen Measles Crisis

HHS Secretary RFK Jr. Pushes Unproven Measles Treatments Amid Rising Outbreak

HHS Mandates Placebo Trials for New Vaccines, Raising Concerns Over COVID Booster Delays

HHS and NIH Launch $500 Million Universal Vaccine Initiative Using Whole-Virus Approach

Moderna Reports Narrower Q1 Loss, Updates Cost-Cutting and Regulatory Timelines

HHS Secretary RFK Jr. Weighs Removing COVID-19 Vaccine From Childhood Schedule

ACIP Reconvenes to Vote on Key Vaccine Updates After Two-Month Delay

RFK Jr. Faces Mounting Criticism Over HHS Leadership and Public Health Policies

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020